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  Oncogenic hyperactivation of the mitotic kinase Aurora-A (AurA) in cancer is associated with 
genomic instability. Increasing evidence indicates that AurA also regulates critical processes in 
normal interphase cells, but the source of such activity has been obscure. We report here that 
multiple stimuli causing release of Ca  2    +       from intracellular endoplasmic reticulum stores rapidly 
and transiently activate AurA, without requirement for second messengers. This activation is 
mediated by direct Ca  2    +      -dependent calmodulin (CaM) binding to multiple motifs on AurA. On 
the basis of structure  –  function analysis and molecular modelling, we map two primary regions 
of CaM-AurA interaction to unfolded sequences in the AurA N- and C-termini. This unexpected 
mechanism for AurA activation provides a new context for evaluating the function of AurA and 
its  inhibitors  in  normal  and  cancerous  cells.             
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   T
he Aurora-A (AurA) kinase is a member of the evolution-
arily conserved Ipl family of kinases (reviewed in Maru-
moto   et al.  1  ). AurA is most abundant at the centrosome in 
G2 to M phase  2  , and in studies performed in mammals and model 
organisms including   Drosophila  , AurA has been shown to be acti-
vated at mitotic entry, performing critical functions in regulat-
ing entry into and passage through mitosis  1,3  . Activation of AurA 
at mitosis is supported by a complex set of interactions between 
the protein and a number of partners, including Ajuba  4 ,  Pak 5 ,  Bora 6 , 
TPX2  7 ,  PPI2 8   and NEDD9  9 .  Th   ese interactions typically occur at the 
centrosome, with the partner proteins supporting AurA localization 
and stability, and inducing allosteric changes that contribute to AurA 
activation. Because of the complex nature of the interactions, the 
exact mechanism timing the abrupt AurA activation at the mitotic 
boundary has not been well resolved. 
  In the past several years, AurA has attracted increasing attention 
because it has been found to be overexpressed and hyperactivated 
in a high percentage of tumours arising in breast, colon, ovary and 
other tissues  10 – 14  . Abnormally high AurA activity is oncogenic in 
various cell line models and is associated with defective cytokinesis 
and aneuploidy  15 – 18  . AurA is now being actively exploited as a target 
for development of new anti-cancer agents (reviewed in Andrews  19 ) 
on the basis of this known role as a mitotic regulator. Interestingly, 
the overexpressed AurA associated with cancer cells has a number 
of activities that are not specifi  c to function in a mitotic compart-
ment. For example, AurA directly phosphorylates and regulates the 
activity of the RalA GTPase, an EGFR  /  Ras eff  ector important in 
many cancers  20 , with this activity observed in interphase cells. AurA 
is not typically mutationally activated in cancer, making the mecha-
nism of its activation in interphase cells somewhat elusive. 
  Intriguingly, a number of studies have emerged in recent years 
to challenge the idea that AurA is solely a mitotic kinase even in 
normal cells. Serum induces AurA activation at the basal body 
of the cell cilium in non-cycling G0  /  G1-phase mammalian cells, 
causing AurA-dependent ciliary resorption  21  , and hence indi-
rectly impacting the functionality of the cilia-dependent and 
cancer-relevant Hedgehog signalling cascades  22  . AurA also has 
been reported to regulate microtubule dynamics in interphase 
cells  23  , and has been shown to be abundantly expressed in some 
human adult non-cycling tissues such as kidney  24  . All these stud-
ies strongly imply a non-mitotic activity for AurA, and indeed, 
a distant ortholog of AurA in the green algae   Chlamydomonas  
regulates both resorption and excision of the fl  agella (a struc-
ture analogous to the mammalian cilium) in response to altered 
ionic conditions or cues for mating  25  , again suggesting important 
non-mitotic roles for AurA, although across a great evolutionary 
distance. However, to date, little eff  ort has been made to inves-
tigate the non-mitotic activation of AurA in either normal cells 
or tumours, and mechanistic insight into factors governing such 
activation is essentially absent. 
  Our previous work demonstrating that AurA activation 
occurs before ciliary resorption in interphase cells  21  was based on 
studies in   Chlamydomonas  , which implicated an AurA ortholog, 
CALK, as important for resorption of flagella in that organism  25 . 
Stimuli that lead to loss of flagella in   Chlamydomonas   include 
mating response to pheromone and transient ionic shock  25 . 
Recent studies in   Chlamydomonas   have also suggested increas-
ing intraflagellar calcium concentrations during the mating 
response  26  , shortly before the activation of the CALK kinase. 
Independently, a study of the   Chlamydomonas   flagellar  excision 
process emphasized the importance of rapid spatiotemporal 
patterning of calcium ion distribution as a critical mediat-
ing signal  27  . Interestingly, a recent study of oocyte maturation 
in   Xenopus   indicated that inhibition of Ca  2    +       signalling led to 
eventual failure to accumulate and activate AurA  28  , although no 
direct connection was investigated. Cumulatively, these studies 
led us to hypothesize that AurA might be a direct target of cel-
lular calcium signalling in mammals. 
  Our work presented here demonstrates that elevated cytoplas-
mic calcium signals are transmitted rapidly and transiently through 
calmodulin (CaM) to activate AurA. Th   is activation involves direct 
CaM binding to two sites in the unstructured regions of AurA, and 
induced by multiple inducers of calcium release from intracellular 
stores in the endoplasmic reticulum (ER). Th   ese results provide the 
fi  rst clear mechanism for AurA activation in non-mitotic cells and 
potential insight into the timing of activation of AurA at mitosis.     
 Results  
  ER release of Ca  2    +        rapidly and transiently activates AurA   .     R a p i d  
and transient Ca  2    +       channel activity is stimulated by treatment of 
kidney cells with the peptide hormone and anti-diuretic arginine 
vasopressin (AVP)  29,30  . AVP signals through the AVPR1 receptor 
to initiate InsP3 and other second-messenger cascades that initiate 
Ca  2    +       release from the ER. Th   e AVPR1 receptor is well expressed in 
the renal cell lines HK-2 and HEK293 (  Fig. 1a  ). To assess whether 
activation of AurA occurred in this physiological context, we treated 
the HK-2 proximal tubule-derived human kidney cell line with 
AVP, and used immunofl  uorescence with antibody directed to T  288  
(auto-phosphorylated)-AurA to measure AurA activation (  Fig. 1b  ). 
Strikingly, T  288  -phospho AurA at centrosomes increased threefold 
within 5     s of AVP treatment, returning to basal levels aft   er   ~ 2   min 
(  Fig. 1c  ), whereas total AurA levels were not aff  ected (  Fig. 1d  ). 
AurA activation might be mediated by Ca  2    +       infl  ux from outside 
the cell, or by Ca  2    +       released from internal ER stores. Using AurA-
transfected HEK293 cells, we found an equivalent degree of AurA 
activation aft  er AVP treatment of cells cultured in medium with and 
without Ca  2    +       (  Fig. 1e  ). To confi  rm that activation was not specifi  c 
to the AVP-initiating stimulus, we also treated these cells grown in 
Ca  2    +      -free medium with histamine, an InsP3 generating agonist that 
triggers activation of ER-associated calcium ion channels such as the 
IP3 receptor  31  . Again T  288  -AurA appeared rapidly aft  er stimulation 
( Fig.  1f ). 
 Th   e fact that rapid AurA activation occurred aft  er stimulation 
of cells grown without extracellular Ca  2    +       implied that the elevated 
cytoplasmic Ca  2    +       levels resulting from ER release might regulate 
AurA activation without intrinsic requirement for second mes-
sengers transmitting signals from membrane-localized receptors. 
To further assess this mechanism, we treated AurA-  transfected 
HEK293 cells with the Ca  2    +       uptake inhibitor thapsigargin, which 
blocks the recycling of cytoplasmic Ca  2    +       into ER stores  32 ,  thus 
increasing cytoplasmic Ca  2    +       levels without the involvement 
of upstream activators. Th  apsigargin treatment caused a rapid 
( <    1   min)  increase  in  levels  of  activated  T 288 -AurA,  and  increased 
the   in vitro   kinase activity of immunoprecipitated AurA against 
defi  ned substrates (  Fig. 2a,b  ). 
  As another test, the BAPTA-AM Ca  2    +       ion chelator blocks Ca  2    +     -
mediated signalling pathway activation  33  ; BAPTA-AM used alone 
or at low concentration in combination with EGTA completely 
blocked thapsigargin-induced T  288 -AurA  auto-phosphorylation 
(  Fig. 2c  ). In the absence of BAPTA-AM, EGTA (which chelates 
only extracellular Ca  2    +      ) had no eff  ect either used alone or in con-
junction with thapsigargin (  Fig. 2d  ). In addition, treatment with 
the Ca  2    +      -selective ionophore, ionomycin, which directly triggers 
Ca  2    +       release, similarly induced transient activation of AurA with 
similar kinetics (  Fig. 2e  ). Further, a small molecule inhibitor of 
AurA, PHA680632  34 , blocked thapsigargin- or ionomycin-induced 
AurA auto-phosphorylation (  Fig. 2f  ). 
 Th  e AurA partner protein, NEDD9, has been shown to be 
important for AurA activation in mitosis and in ciliary resorp-
tion  9,21  , and been shown to be rapidly tyrosine phosphorylated 
(associated with more effi   cient function as an activator for some 
NEDD9 partner proteins) aft  er  Ca  2    +       release in osteoclasts  35,36 . ARTICLE   
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However, in cells transfected with small interfering RNA-depleting 
NEDD9, thapsigargin induced comparable AurA phosphorylation 
to that in control transfected cells (  Fig. 2g  ). Th   ese data indicated 
that calcium-activated AurA phosphorylation is independent 
from NEDD9 activity, causing us to investigate other activation 
mechanisms.   
  C a  2    +      induces CaM to bind and activate AurA   .   Increased cytoplas-
mic Ca  2    +       might induce AurA activation by direct binding or by 
inducing conformational changes in AurA based on AurA binding 
to a Ca  2    +       eff  ector such as CaM. In an   in vitro   kinase assay, titra-
tion of Ca  2    +       into the reaction did not aff  ect AurA auto-phosphor-
ylation or activity towards substrates such as histone H3 (  Fig. 3a  ). 
However, addition of Ca  2    +       with CaM strongly induced AurA 
auto-phosphorylation, as well as AurA phosphorylation of multi-
ple canonical substrates including histone H3, MBP and NEDD9 
(  Fig. 3a  –  c  ). In addition, the AurA inhibitor PHA680632 also 
blocked CaM-induced phosphorylation (  Fig. 3c  ). 
 Th  ese results predicted direct AurA-CaM binding. Th  is bind-
ing was confi  rmed both   in vitro   and   in vivo   (  Fig. 3d, e  ), and was 
positively regulated by Ca  2    +       (  Fig. 3e  ). Treatment with PHA680632 
had no eff  ect on AurA-CaM binding ( Fig. 3f ), as would be expected 
based on defi  ned PHA680632 interactions with a unique site in the 
hinge region of the AurA catalytic domain  37  . CaM pulldown was 
specifi  c to AurA, as a much weaker pulldown was seen with the 
related Ipl kinase AurB and no pulldown was seen with an unrelated 
kinase, Src (  Fig. 3g  ). Further, thapsigargin-induced activation of 
endogenous AurA in HK-2 cells and of transfected AurA in HEK293 
cells was completely blocked by the CaM inhibitor calmidazolium 
(  Fig. 3h, i  ). Using mass spectrometry, we determined that addition 
of CaM to AurA resulted in the appearance of a substantial S  51  or S  53 -
phosphorylated AurA species (QRVLCP-S(51)-NSSQR), as well as 
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       Figure  1     |          Calcium  release  rapidly  induces  AurA  auto-phosphorylation. (  a  ) Western blot assay conﬁ  rming expression of the AVPR1 receptor in cell lines 
used in this study. MCF7 were used as a positive control for AVPR1 expression, based on North   et al.  60 .  ( b )  Immunoﬂ  uorescence of HK-2 cells 30     s after 
stimulation with 100     nM arginine vasopressin (       +       AVP) versus control untreated cells (       −       AVP). Cells were visualized with antibodies to AurA (red) and 
T  288  -phospho-AurA (phAurA, green) and DAPI (blue), as indicated; scale bar, 20       μ  m. Insets show magniﬁ  cation of indicated centrosomes. (  c  ) Analysis of 
data from   b   quantiﬁ  es phAurA-positive cells at times after stimulation. (  d  ) Analysis of data from   b   quantiﬁ  es relative intensity of AurA in cells within 20     s 
after stimulation with AVP. (  e  ) Western blot analysis of AVP-treated HEK293 cells overexpressing AurA in the presence or absence of extracellular Ca  2    +      
chelator (5     mM EGTA) (  f  ) Western blot analysis of phAurA in HEK293 cells transfected with an AurA-expressing plasmid 1  –  2     min after stimulation with 
10    μ  M histamine. For each SDS  –  PAGE,   β  -actin is used as a loading control and molecular weight is indicated in kDa. For   c   and   d  , an average of 150 cells 
were counted. (  c ,   d ,   e )   N     =    3  with  error  bars  indicating  the  standard  error.   *  P     <    0.05.  ARTICLE
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additional phosphorylation events on S  66   or  S 67 ,  and  S 98 .  Interest-
ingly, phosphorylation of S  53   of the   Xenopus   AurA ortholog (analo-
gous to S  51   in human AurA) has been previously shown to be a 
product of mitotic auto-phosphorylation, and to stabilize AurA 
from proteasomal degradation at mitotic exit  38,39 .   
  Defi  nition of CaM-binding sites on AurA   .    CaM  binding  is  typi-
cally modulated by a combination of defi  ned amino acid motifs 
and a disordered secondary structure with the potential to form an 
  α -helix 40  . We used four programs for predicting intrinsically dis-
ordered regions in proteins (IUPRED, MetaPRDOS, PONDR_FIT 
and VL3) to analyse AurA structure (  Fig. 4a  ). Th   is analysis showed 
that consensus regions encompassed within approximately residues 
1 – 127 and 385 – 403 were predicted to be disordered. A crystal struc-
ture of residues 100  –  403 of AurA has been determined  37   (Protein 
Data Bank entry 2J4Z), and only residues 126  –  389 are seen in the 
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       Figure  2     |          Intracellular  calcium  release  is  sufﬁ  cient for AurA activation. (  a  ) HEK293 cells overexpressing AurA were incubated with 5       μ M  thapsigargin 
for the indicated periods of time, and then cell lysates were analysed by western blot. Graph shown below indicates ratio of phAurA to total AurA. (  b ) 
AurA immunoprecipitation and   in vitro   kinase assay, after thapsigargin treatment. HEK293 cells overexpressing AurA were treated with 5       μ M  thapsigargin 
or control dimethylsulpfoxide (DMSO) for 5     min, AurA was immunoprecipitated and incubated with histone H3 substrate in an   in vitro   kinase assay. 
phHH3, antibody to phosphorylated histone H3.   *    P     <    0.05.  ( c  ) Left, an experiment similar to that shown in   a  , except that it is performed in the presence 
of  50    μ  M BAPTA-AM or control DMSO. Right, HEK293 cells overexpressing AurA were incubated with 20       μ  M BAPTA-AM (30     min) plus 7.5     mM EGTA 
(2     min) before the addition of 5       μ  M thapsigargin for the indicated periods of time, with analysis as for   a .  ( d  ) An experiment similar to that shown in   a , 
except that it is performed in the presence of 5     mM EGTA alone for the indicated periods of time (right panel) or in the presence of 5     mM EGTA (2     min) 
before the addition of 5       μ  M thapsigargin. (  e  ) HEK293 cells overexpressing AurA were incubated with 5       μ  M thapsigargin and indicated concentration of 
ionomycin for the indicated periods of time, and then cell lysates were analysed by western blot using indicated antibodies. (  f  ) HK2 cells were treated with 
DMSO,  5    μ  M thapsigargin (Tg) or 0.5       μ  M ionomycin (Ion), and then T  288  -phAurA levels were analysed by enzyme-linked immunosorbent assay (ELISA), 
based on A  450   nm .  To  conﬁ  rm the speciﬁ  city of ELISA signal, a parallel group of HK2 cells were pre-treated with the AurA inhibitor PHA680632 (PHA) 
at  500   nM  concentration.   *  P     <    0.05  .  Lysis  buffer  was  used  as  a  negative  control.  ( g  ) AurA-overexpressing HEK293 cells were transfected with siRNA-
depleting NEDD9 (siNEDD9) or scrambled control siRNA (scr), and then were incubated with 5-  μ  m thapsigargin and processed as in   a  . For this and 
subsequent SDS  –  PAGE analyses, each experiment was performed three times independently, with error bars indicating the standard error.   *    P     <    0.05.  ARTICLE   
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density map, confi  rming the disorder prediction. Th  ese  residues  also 
coincide with the canonical N- and C-terminal kinase domains, for 
example, as defi  ned by the PFAM database  41  . In addition, we used 
the secondary structure prediction program PSIPRED  42,43  on a set of 
AurA orthologs from mammals and   Xenopus   ( Fig.  4b ),  identifying 
two regions of helical propensity in the N-terminal disordered region, 
consisting of residues 59  –  82 and 111  –  127 in the human sequence. 
Th   e C-terminal disordered region is predicted to be coiled, and not 
an   α  -helix or   β  -sheet. However, just before this region, residues 
353 – 364  and  367 – 387  are   α  -helices in the experimental structure. 
 Further  refi   nement of this analysis allowed the mapping of 
a strong minimal interaction domain to residues 33  –  89, and 
suggested weaker binding elements encompassed within residues 
82 – 132,  350 – 368  and  368 – 403  ( Fig.  4c,d ).  Suggestively,  the  mini-
mum strong CaM-AurA-binding site encompassed the longest of 
the predicted   α  -helices in the N-terminal disordered region (resi-
dues 59  –  82), with the   α  -helices adjacent to or containing the Ca  2    +     -
dependent auto-phosphorylation sites (S  51  / S 53   and  S 66  /  S  67 ).  Further, 
the   α  -helix, the phosphorylation sites and the fl  anking sequences 
show striking conservation through mammals (  Fig. 4b  ), implying 
an important function. Th  e weaker binding of CaM to the other 
minimal binding elements may be due to unfolding of the protein in 
some constructs; for example, the predicted helical regions in resi-
dues 350  –  368 are encompassed in the catalytic domain, and would 
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kinase-dead mutant of AurA (K162R) is used for pulldown. (  g  ) Experiment is carried out as in   e  , performed in the presence of 1     mM Ca  2    +     .  ( h )  Western 
blot of lysates from HEK293 cells overexpressing AurA were preincubated for 1     h with 10       μ  M of the CaM inhibitor calmidazolium (CMZ) or control 
DMSO, incubated with 5       μ  M thapsigargin. Graph indicates ratio of phAurA to total AurA, quantiﬁ  ed from analysis of three blots; error bars show standard 
error;   *  P     <    0.05.  ( i  ) HK2 cells were preincubated for 1     h with 10       μ  M CMZ or DMSO, treated with 5-  μ  m thapsigargin for 1     min and then analysed by 
immunoﬂ  uorescence with antibodies to AurA and T  288  -phospho-AurA. An average of 150 cells were counted in each of three experiments, with error bars 
indicating the standard error.   *    P     =    0.00054.  ARTICLE
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normally be folded. However, we cannot rule out local unfolding of 
this region and CaM binding in intact AurA, based on interactions 
of AurA with partner proteins.       
 Discussion 
 Th   e work presented here reveals and mechanistically defi  nes a novel 
role for AurA as a component of rapid calcium signalling responses. 
In interphase cells, we propose that transient stimuli such as AVP 
or histamine trigger Ca  2    +       release into the cytoplasm, inducing CaM 
binding and auto-activation of AurA. Th   ese activities involve diff  er-
ent activation mechanisms than those we have previously reported 
for AurA in regulation of ciliary disassembly  21 ,  occurring  with 
much faster kinetics (2-5     min versus 1  –  2     h) and not infl  uenced by 
depletion of NEDD9. Although our data do not exclude the pos-
sibility that second messengers or cilia-based signalling systems 
may contribute to the activation of AurA in calcium response, they 
argue against an essential requirement for such activation. Such 
transient activation of AurA in response to short-term increases 
in cytoplasmic calcium may off  er a mechanism by which AurA is 
able to phosphorylate targets such as RalA  20   and microtubules  23   in 
non-mitotic cells. Interestingly, RalA is itself regulated by Ca  2    +       in 
a non-Ras-dependent activation pathway  44  , and RalA activity has 
been reported to be controlled by CaM binding  45  . Our data raise 
the possibility that parallel CaM-dependent activation of AurA may 
help control the degree and timing of RalA activation in cancer and 
normal cells. Th   e activation of AurA by Ca  2    +      – CaM  may  also  have 
implications for AurA functions at cilia. Th   e polycystic kidney dis-
ease (PKD)-associated genes   PKD1   and   PKD2   encode  cilia-associ-
ated, heterodimerizing proteins that function as mechanosensors, 
internalizing Ca  2    +       in response to fl  ow-based cues  46 .  Th  is  localized 
release of Ca  2    +       may transiently activate AurA, given the proximal 
location of the AurA protein at the ciliary basal body, allowing 
AurA to phosphorylate substrates relevant to the mechanosensing 
process. For example, AurA exists in a stable complex with NEDD9, 
and NEDD9 (HEF1) has previously been reported to bind the Id2  47 , 
a protein that is phosphorylated and infl  uences cell diff  erentiation 
in response to PKD1  /  PKD2-mediated signalling  48 . 
 Th  ese data also off  er insight into control mechanisms operant 
in the cell cycle-regulated activation of AurA. Dynamic changes in 
calcium signalling have a key role in meiosis, have been implicated 
in action at spindle-associated microdomains in mitosis  49   and  may 
also regulate AurA. An attractive feature of Ca  2    +     -dependent  AurA 
regulation is that it off  ers a potential mechanism to help explain the 
rapid, timed activation of AurA at cell cycle transitions. At present, 
although multiple proteins have been demonstrated to bind and 
support AurA activation at the mitotic boundary, most of these also 
interact with AurA in G2, implying the existence of a triggering 
event at the actual transition point. Th   e transient increase of cyto-
plasmic Ca  2    +       could provide a suitable mitotic trigger. Such Ca  2    +     - 
and CaM-dependent regulation of the centrosomal proteins centrin 
and CP110 has been shown to be critical for the action of these pro-
teins in supporting cytokinesis. In this view, Ca  2    +       release and CaM 
binding may be a physiological trigger for AurA during cell cycle, 
causing conformational changes that are permissive for other AurA-
interacting proteins to sustain its activity during long-term rather 
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     Figure  4     |          Deﬁ  nition of multiple CaM-binding motifs on AurA. 
(  a  ) Prediction of disordered regions in AurA, using programs IUPRED 
(blue), MEtaPRDOS (purple), PONDR_FIT (green) and VLE (red). Higher 
numerical values represent increased likelihood of disorder. (  b )  Sequence 
conservation in the AurA amino-terminus (1  –  127). Predicted   β -sheets  are 
shown in green and   α  -helices in yellow. Arrows indicates Ca2      +      -dependent 
AurA auto-phosphorylation sites. Bold represents highly conserved 
amino acids. (  c  ) Schematic representation of AurA variants used for 
CaM-binding studies. Intensity of binding is indicated by blue shading, 
with dark blue indicating the strongest binding, based on data in   c .  Red 
indicates no binding. (  d  ) Quantitation of binding of AurA domains with 
CaM. Graph indicates ratio of coimmunoprecipitated AurA to total AurA, 
quantiﬁ  ed from analysis of blots from three independent experiments in 
which CaM-Sepharose was used for immunoprecipitation from whole cell 
lysates expressing red ﬂ  uorescent protein (RFP), AurA-RFP and RFP-fused 
domains of AurA, followed by western blotting with antibodies to RFP. 
Bars indicate standard error.   ARTICLE   
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than transient responses. Intriguingly, calcium signalling diff  ers sig-
nifi  cantly in cancerous  50   versus normal cells, promoting increased 
cell proliferation through the abnormal activation of numerous 
calcium-responsive signalling pathways. Hence, our work also 
raises the possibility that the enhanced AurA activity oft  en found 
in tumours may, in part, arise from an abnormal calcium signalling 
environment. Th   ese points merit further investigation.     
 Methods  
  Plasmids and cell culture   .    FLAG-  and  glutathione  S-transferase  (GST)-
fused HEF1 were expressed from the vectors pCatch-FLAG  51   and  pGEX-2T 52 , 
respectively, as previously described. AurA and derivatives were expressed from 
  pCMV-SPORT6-C6   (  OpenBiosystems  ) and pcDNA3.1-mRFP vectors. A PCR 
product  of  mRFP  was  ligated  into   pcDNA3.1(    +    )   ( Invitrogen )  to  create  pcDNA3.1-
mRFP. pcDNA3.1-mRFP was used as a negative control. Catalytically inactive 
AurA (K162R) was prepared using a site-directed mutagenesis kit (  Stratagene  ). 
HEK293 cells were maintained in Dulbecco  ’  s modifi  ed Eagle  ’  s medium with 10  %   
fetal bovine serum plus penicillin  /  streptomycin. Th   e immortalized human kidney 
proximal tubular cell line (  HK-2  ,   ATCC  , cat. no. CRL-219) was grown to subconu-
ence in keratinocyte media (  Invitrogen  ). We transiently transfected HEK293 cells 
with expression constructs for   HEF1   and   AurA   using   Lipofectamine  and  Plus 
reagent   ( Invitrogen )  according  to  the  manufacturer ’ s  instructions.   
  Immunofl  uorescence      .     Cells growing on coverslips were fi  xed with 4  %   paraformal-
dehyde (10     min) and cold methanol (5     min), permeabilized with 1  %   Triton X-100 
in phosphate-buff  ered saline (PBS), blocked in 1  ×   PBS with 3  %   bovine serum albu-
min and incubated with antibodies using standard protocols. Primary antibodies 
included   mouse anti-AurA   (  BD Biosciences  ; 1:200) and   rabbit polyclonal anti-
phospho-AurA  /  T288   (  Cell Signaling  ; 1:100). Secondary antibodies labelled with 
Alexa-488, Alexa-568 and DAPI (4  ’  ,6-diamidino-2-phenylindole) to stain DNA, 
were  from   Mole cular  Probes  /  Invitrogen   (1:2000).  Confocal  microscopy  was  per-
formed using a   Nikon C1 spectral confocal microscope   (  Nikon  ).     
  Western blotting and immunoprecipitation   .    Recombinant  Hexa-histidine  AurA 
was produced in a baculovirus expression system. For western blotting and immu-
noprecipitation, mammalian cells were disrupted in   CelLytic M lysis buff   er   ( Sigma ) 
supplemented with a protease and phosphates inhibitor cocktails (  Roche  ). Whole-
cell lysates were used either directly for SDS polyacrylamide gel electrophoresis 
(SDS  –  PAGE) or for immunoprecipitation. Immuno  precipitation samples were 
incubated overnight with antibody at 4       °  C, and subsequently incubated for 
2     h with   protein A  /  G-sepharose   (  Pierce  ), washed and resolved by SDS  –  PAGE. 
  Western blotting was done using standard procedures, and developed by 
chemiluminescence using the   West-Pico system   (  Pierce  ). Primary antibod-
ies included   mouse anti-NEDD9 mAb   (clone 2G9  9 ;  1:1000),   anti-AurA   ( BD 
Biosciences  ; 1:3000),   anti-phospho-AurA-T  288    and   anti-GST  mAb   ( Cell  Signal-
ing  ; 1:2000),   anti-V1aR   (  Santa Cruz Biotechnology  ; 1:600) and   anti-  β -actin  mAb  
(AC15,   Sigma  ;1:20,000). Polyclonal anti-AurA agarose-immobilized conjugate 
(  Bethyl  ) were used for immunoprecipitations. Secondary anti-mouse and anti-
rabbit horseradish peroxidase-conjugated antibodies (  GE Healthcare  ) were used 
at a dilution of 1:10,000 for visualization of western blots. Image analysis was done 
using   NIH ImageJ    —  Image Processing and Analysis soft  ware (  National Institutes of 
Health  ), with signal intensity normalized to   β  -actin or total AurA level.     
  Structural analysis   .    Four  programs  that  predict  intrinsically  disordered  regions 
were used via their webservers:   IUPRED    53 ,   MetaPRDOS  54 ,   PONDR_FIT  55   and 
 VL3  56 .   PSI-BLAST  57   was used to search the Uniprot database  58   to  fi  nd orthologs 
of AurA and to identify crystal structures of AurA in the Protein Data Bank. A 
selection of these sequences was retrieved and a multiple sequence alignment was 
performed with   Clustal W    59 .  Th   e program   PSIPRED    43   was used to predict second-
ary structure for these sequences based on single sequence predictions, rather than 
multiple sequence alignments from PSI-BLAST.     
  CaM association studies   .    Cell  lysates  in  lysis  buff  er (PBS with 1  %   Triton X-100) or 
purifi  ed GST fusion protein diluted in binding buff  er (50     mM Tris  –  HCl (pH 7.6), 
120     mM NaCl, 1  %   Brij) were incubated with   CaM-Sepharose 4B   (  GE Health-
care  ) or control Sepharose for 1  –  2     h at 4       °  C, as indicated in the fi  gure legends. In 
defi  ned   in vitro   experiments, AurA was purifi  ed from baculovirus, as previously 
described  21  , whereas recombinant proteins   AurB   or   Src   were obtained from 
 Millipore .  Aft  er washing, beads were boiled in SDS sample buff  er and separated by 
SDS  –  PAGE followed by western blotting.     
  Phosphorylation assays   .    MBP,   histone  H3   ( Upstate )  and   histone  H1   ( Upstate ) 
were used as positive and negative controls for AurA phosphorylation using stand-
ard methods. Parallel aliquots without   γ - 32 P(ATP)  were  processed  for  SDS – PAGE /
  Coomassie staining (  Invitrogen  ). To assess CaM-dependent AurA activation, 
  in vitro   kinase assay was performed using AurA purifi  ed from baculovirus or 
according the protocol described above, in the presence of 1       μ M   CaM   ( Calbiochem ) 
and  1   mM  Ca 2    +      . For kinase assay without Ca  2    +      , 1     mM EGTA was substituted for 
1   mM  Ca 2    +       in the kinase buff  er. Endogenous phospho-T  288  -AurA protein in HK2 
cells was detected by   PathScan Phospho-AurA Sandwich ELISA kit   (  Cell Signaling  ) 
according to the manufacturer  ’  s instructions.     
  Mass spectrometry   .     A ft er an   in vitro   kinase reaction with AurA produced from 
baculovirus in the presence or absence of CaM plus 1     mM CaCl  2  , gels were stained 
with Coomassie blue and phospho  rylated AurA bands were excised and sequenced 
at the Taplin Biological Mass Spectrometry Facility at Harvard Medical School, by 
using microcapillary reverse-phase HPLC nanoelectrospray tandem mass spec-
trometry on a Finnigan LCQ DECA quadrupole ion trap mass spectrometer.     
  Statistical analysis   .    Statistical  comparisons  were  made  using  a  two-tailed  Student ’ s 
  t  -test. Experimental values were reported as the means   ±   s.e.  Diff  erences in mean 
values were considered signifi  cant at   P     <    0.05.  All  calculations  of  statistical  signifi  -
cance were made using the   GraphPad InStat soft   ware  package   ( GraphPad ).                
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